Klebsiella pneumoniae ST147: and then there were three carbapenemases.


Journal

European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology
ISSN: 1435-4373
Titre abrégé: Eur J Clin Microbiol Infect Dis
Pays: Germany
ID NLM: 8804297

Informations de publication

Date de publication:
Dec 2022
Historique:
received: 16 08 2022
accepted: 18 10 2022
pubmed: 23 10 2022
medline: 8 11 2022
entrez: 22 10 2022
Statut: ppublish

Résumé

Gram-negative bacteria containing three different carbapenemases are extremely rare. Klebsiella pneumoniae (N22-925) with KPC-2, NDM-1, and OXA-48 was obtained from a Canadian patient with recent hospitalization in Romania. Short and long read whole genome sequencing showed that the bla

Identifiants

pubmed: 36271303
doi: 10.1007/s10096-022-04514-4
pii: 10.1007/s10096-022-04514-4
doi:

Substances chimiques

carbapenemase EC 3.5.2.6
Anti-Bacterial Agents 0
beta-Lactamases EC 3.5.2.6
Bacterial Proteins 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1467-1472

Informations de copyright

© 2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Références

Tacconelli E, Carrara E, Savoldi A, Harbarth S, Mendelson M, Monnet DL, Pulcini C, Kahlmeter G, Kluytmans J, Carmeli Y, Ouellette M, Outterson K, Patel J, Cavaleri M, Cox EM, Houchens CR, Grayson ML, Hansen P, Singh N, Theuretzbacher U, Magrini N, Group WHOPPLW (2018) Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis. Lancet Infect Dis 18(3):318–327
doi: 10.1016/S1473-3099(17)30753-3
Pitout JD, Nordmann P, Poirel L (2015) Carbapenemase-producing Klebsiella pneumoniae, a key pathogen set for global nosocomial dominance. Antimicrob Agents Chemother 59(10):5873–5884
doi: 10.1128/AAC.01019-15 pubmed: 26169401 pmcid: 4576115
Karlowsky JA, Lob SH, Kazmierczak KM, Young K, Motyl MR, Sahm DF (2020) In vitro activity of imipenem/relebactam against Enterobacteriaceae and Pseudomonas aeruginosa isolated from intraabdominal and urinary tract infection samples: SMART Surveillance United States 2015–2017. J Glob Antimicrob Resist 21:223–228
doi: 10.1016/j.jgar.2019.10.028 pubmed: 31698105
Kazmierczak KM, Karlowsky JA, de Jonge BLM, Stone GG, Sahm DF (2021) Epidemiology of carbapenem resistance determinants identified in meropenem-nonsusceptible Enterobacterales collected as part of a global surveillance program, 2012 to 2017. Antimicrob Agents Chemother 65(7):e0200020
doi: 10.1128/AAC.02000-20 pubmed: 33972241
Peirano G, Chen L, Nobrega D, Finn TJ, Kreiswirth BN, DeVinney R, Pitout JDD (2022) Genomic epidemiology of global carbapenemase-producing Escherichia coli, 2015–2017. Emerg Infect Dis 28(5):924–31
doi: 10.3201/eid2805.212535 pmcid: 9045447
van der Bij AK, Pitout JD (2012) The role of international travel in the worldwide spread of multiresistant Enterobacteriaceae. J Antimicrob Chemother 67(9):2090–2100
doi: 10.1093/jac/dks214 pubmed: 22678728
Peirano G, Pillai DR, Pitondo-Silva A, Richardson D, Pitout JD (2011) The characteristics of NDM-producing Klebsiella pneumoniae from Canada. Diagn Microbiol Infect Dis 71(2):106–109
doi: 10.1016/j.diagmicrobio.2011.06.013 pubmed: 21924993
Mulvey MR, Grant JM, Plewes K, Roscoe D, Boyd DA (2011) New Delhi metallo-beta-lactamase in Klebsiella pneumoniae and Escherichia coli. Canada Emerg Infect Dis 17(1):103–106
doi: 10.3201/eid1701.101358 pubmed: 21192866
Moser AI, Keller PM, Campos-Madueno EI, Poirel L, Nordmann P, Endimiani A (2021) A patient with multiple carbapenemase producers including an unusual Citrobacter sedlakii hosting an IncC bla NDM-1- and armA-carrying plasmid. Pathog Immun 6(2):119–134
doi: 10.20411/pai.v6i2.482 pubmed: 34988342 pmcid: 8714174
Ahmed-Bentley J, Chandran AU, Joffe AM, French D, Peirano G, Pitout JD (2013) Gram-negative bacteria that produce carbapenemases causing death attributed to recent foreign hospitalization. Antimicrob Agents Chemother 57(7):3085–3091
doi: 10.1128/AAC.00297-13 pubmed: 23612195 pmcid: 3697334
Mataseje LF, Peirano G, Church DL, Conly J, Mulvey M, Pitout JD (2016) Colistin-nonsusceptible Pseudomonas aeruginosa sequence type 654 with blaNDM-1 arrives in North America. Antimicrob Agents Chemother 60(3):1794–1800
doi: 10.1128/AAC.02591-15 pubmed: 26824951 pmcid: 4775918
Chan WW, Campbell L, Doyle D, Pitout JD (2020) Rapid detection of Enterobacterales that produce carbapenemases. Diagn Microbiol Infect Dis 98(2):115120
doi: 10.1016/j.diagmicrobio.2020.115120 pubmed: 32688297
Doyle D, Peirano G, Lascols C, Lloyd T, Church DL, Pitout JD (2012) Laboratory detection of Enterobacteriaceae that produce carbapenemases. J Clin Microbiol 50(12):3877–3880
doi: 10.1128/JCM.02117-12 pubmed: 22993175 pmcid: 3503014
CLSI (2013) M100-S23 Performance standards for antimicrobial susceptibility testing. Clinical and Laboratory Standards Institute, Wayne, PA
Wick RR, Judd LM, Gorrie CL, Holt KE (2017) Unicycler: resolving bacterial genome assemblies from short and long sequencing reads. PLoS Comput Biol 13(6):e1005595
doi: 10.1371/journal.pcbi.1005595 pubmed: 28594827 pmcid: 5481147
Nohejl T, Valcek A, Papousek I, Palkovicova J, Wailan AM, Pratova H, Minoia M, Dolejska M (2022) Genomic analysis of qnr-harbouring IncX plasmids and their transferability within different hosts under induced stress. BMC Microbiol 22(1):136
doi: 10.1186/s12866-022-02546-6 pubmed: 35590235 pmcid: 9118779
Matsumura Y, Pitout JD (2016) Recent advances in the laboratory detection of carbapenemase-producing Enterobacteriaceae. Expert Rev Mol Diagn 16(7):783–794
doi: 10.1586/14737159.2016.1172964 pubmed: 27042955
Peirano G, Chen L, Kreiswirth BN, Pitout JDD (2020) Emerging antimicrobial-resistant high-risk Klebsiella pneumoniae clones ST307 and ST147. Antimicrob Agents Chemother 64(10):e01148–20
Teban-Man A, Farkas A, Baricz A, Hegedus A, Szekeres E, Parvu M, Coman C (2021) Wastewaters, with or without hospital contribution, harbour MDR, carbapenemase-producing, but not hypervirulent Klebsiella pneumoniae. Antibiotics (Basel) 10(4):361
Mathers AJ, Peirano G, Pitout JD (2015) The role of epidemic resistance plasmids and international high-risk clones in the spread of multidrug-resistant Enterobacteriaceae. Clin Microbiol Rev 28(3):565–591
doi: 10.1128/CMR.00116-14 pubmed: 25926236 pmcid: 4405625
Treangen TJ, Ondov BD, Koren S, Phillippy AM (2014) The harvest suite for rapid core-genome alignment and visualization of thousands of intraspecific microbial genomes. Genome Biol 15(11):524
doi: 10.1186/s13059-014-0524-x pubmed: 25410596 pmcid: 4262987
van Duin D, Perez F, Rudin SD, Cober E, Hanrahan J, Ziegler J, Webber R, Fox J, Mason P, Richter SS, Cline M, Hall GS, Kaye KS, Jacobs MR, Kalayjian RC, Salata RA, Segre JA, Conlan S, Evans S, Fowler VG Jr, Bonomo RA (2014) Surveillance of carbapenem-resistant Klebsiella pneumoniae: tracking molecular epidemiology and outcomes through a regional network. Antimicrob Agents Chemother 58(7):4035–4041
doi: 10.1128/AAC.02636-14 pubmed: 24798270 pmcid: 4068524
Carattoli A, Hasman H (2020) PlasmidFinder and in silico pMLST: identification and typing of plasmid replicons in whole-genome sequencing (WGS). Methods Mol Biol 2075:285–294
doi: 10.1007/978-1-4939-9877-7_20 pubmed: 31584170
Dolejska M, Villa L, Dobiasova H, Fortini D, Feudi C, Carattoli A (2013) Plasmid content of a clinically relevant Klebsiella pneumoniae clone from the Czech Republic producing CTX-M-15 and QnrB1. Antimicrob Agents Chemother 57(2):1073–1076
doi: 10.1128/AAC.01886-12 pubmed: 23229477 pmcid: 3553734
Pitout JDD, Peirano G, Kock MM, Strydom KA, Matsumura Y (2019) The global ascendency of OXA-48-type carbapenemases. Clin Microbiol Rev 33(1):e00102–19

Auteurs

L F Mataseje (LF)

National Microbiology Laboratory, Winnipeg, MB, Canada.

L Chen (L)

Center for Discovery and Innovation, Hackensack Meridian Health, Nutley, USA.
Hackensack Meridian School of Medicine at, Seton Hall University, Nutley, NJ, USA.

G Peirano (G)

Division of Microbiology, Alberta Precision Laboratories, Calgary, AB, Canada.
Cummings School of Medicine, University of Calgary, 3535 Research Road NW, Calgary, AB, #9T2L 2K8, Canada.

K Fakharuddin (K)

National Microbiology Laboratory, Winnipeg, MB, Canada.

B Kreiswith (B)

Center for Discovery and Innovation, Hackensack Meridian Health, Nutley, USA.
Hackensack Meridian School of Medicine at, Seton Hall University, Nutley, NJ, USA.

M Mulvey (M)

National Microbiology Laboratory, Winnipeg, MB, Canada.

J D D Pitout (JDD)

Division of Microbiology, Alberta Precision Laboratories, Calgary, AB, Canada. jpitout@ucalgary.ca.
Cummings School of Medicine, University of Calgary, 3535 Research Road NW, Calgary, AB, #9T2L 2K8, Canada. jpitout@ucalgary.ca.
University of Pretoria, Pretoria, Gauteng, South Africa. jpitout@ucalgary.ca.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH